B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA

References

• Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021;17:1446–14. doi:10.7150/ijbs.59233.
   PubMed Web of Science ®Google Scholar
• Hogan MJ, Pardi N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med. 2022;73:17–39. doi:10.1146/annurev-med-042420-112725.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261–279. doi:10.1038/nrd.2017.243.
   PubMed Web of Science ®Google Scholar
• Xu S, Yang K, Li R, Zhang L. mRNA vaccine era—Mechanisms, drug platform and clinical prospection. Int J Mol Sci. 2020;21:6582. doi:10.3390/ijms21186582.
   PubMed Web of Science ®Google Scholar
• Vogel FR, Sarver N. Nucleic acid vaccines. Clin Microbiol Rev. 1995;8:406–410. doi:10.1128/CMR.8.3.406.
   PubMed Web of Science ®Google Scholar
• Yang B, Jeang J, Yang A, Wu TC, Hung CF. DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother. 2014;10:3153–3164. doi:10.4161/21645515.2014.980686.
   PubMed Web of Science ®Google Scholar
• Grosenbaugh DA, Leard AT, Bergman PJ, Klein MK, Meleo K, Susaneck S. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. American journal of veterinary research. 2011;72:1631–8. doi:10.2460/ajvr.72.12.1631.
   PubMed Web of Science ®Google Scholar
• Liu MA, Ulmer JB. Human clinical trials of plasmid DNA vaccines. Adv Genet. 2005;55:25–40.
   PubMed Web of Science ®Google Scholar
• Moss RB. Prospects for control of emerging infectious diseases with plasmid DNA vaccines. J Immune Based Ther Vaccines. 2009;7:3. doi:10.1186/1476-8518-7-3.
   PubMedGoogle Scholar
• Robinson HL. DNA vaccines: basic mechanism and immune responses (Review). Int J Mol Med. 1999;4:549–555. doi:10.3892/ijmm.4.5.549.
   PubMed Web of Science ®Google Scholar
• Lauterbach H, Gruber A, Ried C, Cheminay C, Brocker T. Insufficient APC capacities of dendritic cells in gene gun-mediated DNA vaccination. J Immunol. 2006;176:4600–4607. doi:10.4049/jimmunol.176.8.4600.
   PubMed Web of Science ®Google Scholar
• Hobernik D, Bros M. DNA vaccines—How far from clinical use? Int J Mol Sci. 2018;19:3605. doi:10.3390/ijms19113605.
   PubMed Web of Science ®Google Scholar
• Colluru VT, McNeel DG. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines. Oncotarget. 2016;7:67901–67918. doi:10.18632/oncotarget.12178.
   PubMedGoogle Scholar
• Johnson LE, Frye TP, Arnot AR, Marquette C, Couture LA, Gendron-Fitzpatrick A, McNeel DG. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP). Vaccine. 2006;24:293–303. doi:10.1016/j.vaccine.2005.07.074.
   PubMed Web of Science ®Google Scholar
• Kapadia D, Sadikovic A, Vanloubbeeck Y, Brockstedt D, Fong L. Interplay between CD8alpha+ dendritic cells and monocytes in response to Listeria monocytogenes infection attenuates T cell responses. PLoS One. 2011; 6:e19376. 10.1371/journal.pone.0019376.
   Google Scholar
• Afgan E, Baker D, Batut B, van den Beek M, Bouvier D, Cech M, Chilton J, Clements D, Coraor N, Gruning BA, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46:W537–544. doi:10.1093/nar/gky379.
   PubMed Web of Science ®Google Scholar
• Toellner KM. Cognate interactions: extrafollicular IL-4 drives germinal-center reactions, a new role for an old cytokine. Eur J Immunol. 2014;44:1917–1920. doi:10.1002/eji.201444825.
   PubMed Web of Science ®Google Scholar
• Butch AW, Chung GH, Hoffmann JW, Nahm MH. Cytokine expression by germinal center cells. J Immunol. 1993;150:39–47. doi:10.4049/jimmunol.150.1.39.
   PubMed Web of Science ®Google Scholar
• Tadmori W, Lee HK, Clark SC, Choi YS. Human B cell proliferation in response to IL-4 is associated with enhanced production of B cell-derived growth factors. J Immunol. 1989;142:826–832. doi:10.4049/jimmunol.142.3.826.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–15550. doi:10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267–273. doi:10.1038/ng1180.
   PubMed Web of Science ®Google Scholar
• Papa I, Vinuesa CG. Synaptic interactions in germinal centers. Front Immunol. 2018;9:1858. doi:10.3389/fimmu.2018.01858.
   PubMed Web of Science ®Google Scholar
• Koopman G, Keehnen RM, Lindhout E, Newman W, Shimizu Y, van Seventer GA, de Groot C, Pals ST. Adhesion through the LFA-1 (Cd11a/cd18)-ICAM-1 (CD54) and the VLA-4 (Cd49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J Immunol. 1994;152:3760–3767. doi:10.4049/jimmunol.152.8.3760.
   PubMed Web of Science ®Google Scholar
• Carrasco YR, Fleire SJ, Cameron T, Dustin ML, Batista FD. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity. 2004;20:589–599. doi:10.1016/S1074-7613(04)00105-0.
   PubMed Web of Science ®Google Scholar
• Smulski CR, Eibel H. BAFF and BAFF-Receptor in B cell selection and survival. Front Immunol. 2018;9:2285. doi:10.3389/fimmu.2018.02285.
   PubMed Web of Science ®Google Scholar
• Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol. 2006;18:290–296. doi:10.1016/j.smim.2006.06.002.
   PubMed Web of Science ®Google Scholar
• Treanor B. B-cell receptor: from resting state to activate. Immunology. 2012;136:21–27. doi:10.1111/j.1365-2567.2012.03564.x.
   PubMed Web of Science ®Google Scholar
• Avalos AM, Ploegh HL. Early BCR events and antigen capture, processing, and loading on MHC class II on B cells. Front Immunol. 2014;5:92. doi:10.3389/fimmu.2014.00092.
   PubMed Web of Science ®Google Scholar
• Tomai MA, Imbertson LM, Stanczak TL, Tygrett LT, Waldschmidt TJ. The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes. Cell Immunol. 2000;203:55–65. doi:10.1006/cimm.2000.1673.
   PubMed Web of Science ®Google Scholar
• Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, et al. Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 2019;5. doi:10.1172/jci.insight.129641.
   PubMedGoogle Scholar
• Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, Lepelley A, Becht E, Katsahian S, Bizouard G, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189:832–844. doi:10.1164/rccm.201309-1611OC.
   PubMed Web of Science ®Google Scholar
• Zahm CD, Moseman JE, Delmastro LE, GM D. PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy. Oncoimmunology. 2021;10:1912892. doi:10.1080/2162402X.2021.1912892.
   PubMed Web of Science ®Google Scholar